Hydroxychloroquine (HCQ) is a valuable and possibly underused agent in treating mild lupus. Whether this drug should be discontinued in pregnancy is still controversial. We studied the full obstetric histories of 33 women with lupus who had taken HCQ at some point during pregnancy. HCQ was not, apparently, teratogenic and we believe that continuation of this drug is probably safe in lupus pregnancies.
The Canadian hydroxychloroquine study group: a randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.N Engl J Med1991; 324: 150–154.
6.
ParkeAL.Antimalarial drugs, pregnancy and lactation.Lupus1993; 2(Suppl 1): S21–S23.
7.
BuchananNM. Practical management of pregnancy in systemic lupus erythematosus.Fetal Mat Med Review1993; 5: 223–230.
8.
Ruiz-IrastorzaG. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies.Br J Rheumatol1996; 35: 133–138.
9.
TanEM. The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1982; 25: 1272–1277.
10.
BuchananNMM. Hydroxychloroquine and lupus pregnancy: a review of a series of 36 cases.Ann Rheum Dis1996; In press.
11.
JohnsonR, OrthMC, CharnleyJ.Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty.Clin Orthop1979; 144: 174–1777.
WallaceDJ, Linker-IsraeliM, MetzgerA, StecherVJ.The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE.Lupus1993; 2 (Suppl 1): S13–S15.
14.
PetriM. Incidence of and predictors of thrombotic events in SLE: Protective role of hydroxychloroquine.Arthritis Rheum1992; 35 (Suppl): S54.
